Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell transplantation in children with spinal muscular atrophy
ChiCTR-ONC-11001420Phase 2Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Jul 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in spinal muscular atrophy (SMA), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoint: Gait analysis. Started Jul 2011; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on ChiCTR-ONC-11001420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001420.